{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:31:01Z","timestamp":1776771061868,"version":"3.51.2"},"reference-count":106,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904072"],"award-info":[{"award-number":["81904072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2018YFC1704102"],"award-info":[{"award-number":["2018YFC1704102"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Training Program of Xing-lin Heritage-type Talents in Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["A1-W20-205-01-0402-18"],"award-info":[{"award-number":["A1-W20-205-01-0402-18"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Climbing and Trekking Talent Training Program in Basic Medical College, Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["A1-GY20-101-0101"],"award-info":[{"award-number":["A1-GY20-101-0101"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>At present, timely and accurate diagnosis and effective treatment of Epstein-\nBarr Virus (EBV) infection-associated fever remain a difficult challenge. EBV encodes\n44 mature microRNAs (miRNAs) that inhibit viral lysis, adjust inflammatory response,\nregulate cellular apoptosis, promote tumor genesis and metastasis, and regulate\ntumor cell metabolism. Herein, we have collected the specific expression data of\nEBV-miRNAs in EBV-related fevers, including infectious mononucleosis (IM), EBVassociated\nhemophagocytic lymphohistiocytosis (EBV-HLH), chronic active EBV infection\n(CAEBV), and EBV-related tumors, and proposed the potential value of EBVmiRNAs\nas biomarkers to assist in the identification, diagnosis, and prognosis of EBVrelated\nfever, as well as therapeutic targets for drug development.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524023666221118122005","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T05:37:19Z","timestamp":1669095439000},"page":"2-13","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["EBV-microRNAs as Potential Biomarkers in EBV-related Fever:\nA Narrative Review"],"prefix":"10.2174","volume":"24","author":[{"given":"Wei-ting","family":"Wang","sequence":"first","affiliation":[{"name":"School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai (201203), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-8204","authenticated-orcid":true,"given":"Yun","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine,\nShanghai (201203), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Information Center of Science and Technology, Shanghai Innovation Center of\nTCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai (201203), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-ning","family":"Le","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Medical Immunology &amp; Institute of Immunology, Second Military Medical University,\nShanghai (200433), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-lin","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine,\nShanghai (201203), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Longhua Hospital, Shanghai University of Traditional Chinese Medicine,\nShanghai (200032), China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9502-1730","authenticated-orcid":true,"given":"Yan-jie","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Febrile Disease, Basic Medical College, Shanghai University of\nTraditional Chinese Medicine, Shanghai (201203), China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1252786","volume":"343","author":"Lieberman P.M.","year":"2014","unstructured":"Lieberman P.M.; Virology. Epstein-Barr virus turns 50. Science 2014,343(6177),1323-1325","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","volume":"17","author":"M\u00fcnz C.","year":"2019","unstructured":"M\u00fcnz C.; Latency and lytic replication in Epstein\u2013Barr virus-associated oncogenesis. Nat Rev Microbiol 2019,17(11),691-700","journal-title":"Nat Rev Microbiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"Young L.S.","year":"2004","unstructured":"Young L.S.; Rickinson A.B.; Epstein\u2013Barr virus: 40 years on. Nat Rev Cancer 2004,4(10),757-768","journal-title":"Nat Rev Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/icb.1995.79","volume":"73","author":"Schmidt C.W.","year":"1995","unstructured":"Schmidt C.W.; Misko I.S.; The ecology and pathology of Epstein-Barr virus. Immunol Cell Biol 1995,73(6),489-504","journal-title":"Immunol Cell Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","volume":"72","author":"Kerr J.R.","year":"2019","unstructured":"Kerr J.R.; Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol 2019,72(10),651-658","journal-title":"J Clin Pathol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-319-22834-1_8","volume":"391","author":"McKenzie J.","year":"2015","unstructured":"McKenzie J.; El-Guindy A.; Epstein-barr virus lytic cycle reactivation. Curr Top Microbiol Immunol 2015,391,237-261","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0092-8674(88)90028-1","volume":"55","author":"Hammerschmidt W.","year":"1988","unstructured":"Hammerschmidt W.; Sugden B.; Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 1988,55(3),427-433","journal-title":"Cell"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/viro.1996.0325","volume":"220","author":"Schepers A.","year":"1996","unstructured":"Schepers A.; Pich D.; Hammerschmidt W.; Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 1996,220(2),367-376","journal-title":"Virology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"Pfeffer S.","year":"2004","unstructured":"Pfeffer S.; Zavolan M.; Gr\u00e4sser F.A.; Identification of virus-encoded microRNAs. Science 2004,304(5671),734-736","journal-title":"Science"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e01941","DOI":"10.1128\/mBio.01941-18","volume":"10","author":"Murer A.","year":"2019","unstructured":"Murer A.; R\u00fchl J.; Zbinden A.; MicroRNAs of epstein-barr virus attenuate T-cell-mediated immune control in vivo. MBio 2019,10(1),e01941-e18","journal-title":"MBio"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"Lu T.X.","year":"2018","unstructured":"Lu T.X.; Rothenberg M.E.; Micro R.N.A.; MicroRNA. J Allergy Clin Immunol 2018,141(4),1202-1207","journal-title":"J Allergy Clin Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-319-22834-1_9","volume":"391","author":"L\u00fcnemann A.","year":"2015","unstructured":"L\u00fcnemann A.; Rowe M.; Nadal D.; Innate immune recognition of EBV. Curr Top Microbiol Immunol 2015,391,265-287","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"Saliminejad K.","year":"2019","unstructured":"Saliminejad K.; Khorram Khorshid H.R.; Soleymani Fard S.; Ghaffari S.H.; An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 2019,234(5),5451-5465","journal-title":"J Cell Physiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1021\/cr300362f","volume":"113","author":"Dong H.","year":"2013","unstructured":"Dong H.; Lei J.; Ding L.; MicroRNA: Function, detection, and bioanalysis. Chem Rev 2013,113(8),6207-6233","journal-title":"Chem Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrc.2016.56","volume":"16","author":"Vargas A.J.","year":"2016","unstructured":"Vargas A.J.; Harris C.C.; Biomarker development in the precision medicine era: Lung cancer as a case study. Nat Rev Cancer 2016,16(8),525-537","journal-title":"Nat Rev Cancer"},{"key":"ref=16","author":"Biomarker Working F.D.A-N.I.H.G.","year":"2016","unstructured":"Biomarker Working F.D.A-N.I.H.G.;  BEST (Biomarkers, EndpointS, and other Tools) 2016","journal-title":"BEST (Biomarkers, EndpointS, and other Tools)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","year":"2001","unstructured":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther Biomarkers Definitions Working Group2001,69(3),89-95","journal-title":"Clin Pharmacol Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbagrm.2011.05.010","volume":"1809","author":"Barth S.","year":"2011","unstructured":"Barth S.; Meister G.; Gr\u00e4sser F.A.; EBV-encoded miRNAs. Biochim Biophys Acta Gene Regul Mech 2011,1809(11-12),631-640","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.02.002","volume":"26","author":"Klinke O.","year":"2014","unstructured":"Klinke O.; Feederle R.; Delecluse H.J.; Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 2014,26,52-59","journal-title":"Semin Cancer Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3389\/fmicb.2014.00728","volume":"5","author":"Navari M.","year":"2014","unstructured":"Navari M.; Fuligni F.; Laginestra M.A.; Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and posttransplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Front Microbiol 2014,5,728","journal-title":"Front Microbiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cam4.1006","volume":"6","author":"Sakamoto K.","year":"2017","unstructured":"Sakamoto K.; Sekizuka T.; Uehara T.; Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas. Cancer Med 2017,6(3),605-618","journal-title":"Cancer Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/JVI.01528-10","volume":"85","author":"Amoroso R.","year":"2011","unstructured":"Amoroso R.; Fitzsimmons L.; Thomas W.A.; Kelly G.L.; Rowe M.; Bell A.I.; Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J Virol 2011,85(2),996-1010","journal-title":"J Virol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","volume":"1045","author":"Kanda T.","year":"2018","unstructured":"Kanda T.; EBV-encoded latent genes. Adv Exp Med Biol 2018,1045,377-394","journal-title":"Adv Exp Med Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.omtn.2019.07.002","volume":"17","author":"Wang M.","year":"2019","unstructured":"Wang M.; Gu B.; Chen X.; Wang Y.; Li P.; Wang K.; The function and therapeutic potential of epstein-barr virus-encoded MicroRNAs in cancer. Mol Ther Nucleic Acids 2019,17,657-668","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7150\/ijbs.24562","volume":"14","author":"Wang M.","year":"2018","unstructured":"Wang M.; Yu F.; Wu W.; Wang Y.; Ding H.; Qian L.; Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. Int J Biol Sci 2018,14(5),565-576","journal-title":"Int J Biol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"Kalluri R.","year":"2020","unstructured":"Kalluri R.; LeBleu V.S.; The biology, function, and biomedical applications of exosomes. Science 2020,367(6478),eaau6977","journal-title":"Science"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/or.2021.8224","volume":"47","author":"Chen W.","year":"2021","unstructured":"Chen W.; Xie Y.; Wang T.; Wang L.; New insights into Epstein Barr virus associated tumors: Exosomes (Review). Oncol Rep 2021,47(1),13","journal-title":"Oncol Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1073\/pnas.0914843107","volume":"107","author":"Pegtel D.M.","year":"2010","unstructured":"Pegtel D.M.; Cosmopoulos K.; Thorley-Lawson D.A.; Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010,107(14),6328-6333","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"CD011487","DOI":"10.1002\/14651858.CD011487.pub2","volume":"2016","author":"De Paor M.","year":"2016","unstructured":"De Paor M.; O\u2019Brien K.; Fahey T.; Smith S.M.; Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Libr 2016,2016(12),CD011487","journal-title":"Cochrane Libr"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"Luzuriaga K.","year":"2010","unstructured":"Luzuriaga K.; Sullivan J.L.; Infectious mononucleosis. N Engl J Med 2010,362(21),1993-2000","journal-title":"N Engl J Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/pathogens9030226","volume":"9","author":"Abusalah M.A.H.","year":"2020","unstructured":"Abusalah M.A.H.; Gan S.H.; Al-Hatamleh M.A.I.; Irekeola A.A.; Shueb R.H.; Yean Yean C.; Recent advances in diagnostic approaches for epstein\u2013barr virus. Pathogens 2020,9(3),226","journal-title":"Pathogens"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fonc.2019.00062","volume":"9","author":"Kimura H.","year":"2019","unstructured":"Kimura H.; Kwong Y.L.; EBV viral loads in diagnosis, monitoring, and response assessment. Front Oncol 2019,9,62","journal-title":"Front Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12875-019-0954-3","volume":"20","author":"Fugl A.","year":"2019","unstructured":"Fugl A.; Andersen C.L.; Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Fam Pract 2019,20(1),62","journal-title":"BMC Fam Pract"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","volume":"72","author":"Aggarwal B.B.","year":"2006","unstructured":"Aggarwal B.B.; Shishodia S.; Sandur S.K.; Pandey M.K.; Sethi G.; Inflammation and cancer: How hot is the link? Biochem Pharmacol 2006,72(11),1605-1621","journal-title":"Biochem Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"Fajgenbaum D.C.","year":"2020","unstructured":"Fajgenbaum D.C.; June C.H.; Cytokine storm. N Engl J Med 2020,383(23),2255-2273","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","volume":"98","author":"Kasahara Y.","year":"2001","unstructured":"Kasahara Y.; Yachie A.; Takei K.; Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001,98(6),1882-1888","journal-title":"Blood"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"e2013066","DOI":"10.4084\/mjhid.2013.066","volume":"5","author":"Bay A.","year":"2013","unstructured":"Bay A.; Coskun E.; Oztuzcu S.; Ergun S.; Yilmaz F.; Aktekin E.; Evaluation of the plasma micro RNA expression levels in secondary hemophagocytic lymphohistiocytosis. Mediterr J Hematol Infect Dis 2013,5(1),e2013066","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e1009217","DOI":"10.1371\/journal.ppat.1009217","volume":"17","author":"Ungerleider N.","year":"2021","unstructured":"Ungerleider N.; Bullard W.; Kara M.; EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. PLoS Pathog 2021,17(5),e1009217","journal-title":"PLoS Pathog"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2010.03.008","volume":"7","author":"D\u00f6lken L.","year":"2010","unstructured":"D\u00f6lken L.; Malterer G.; Erhard F.; Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010,7(4),324-334","journal-title":"Cell Host Microbe"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1534\/genetics.109.107540","volume":"183","author":"Yang I.V.","year":"2009","unstructured":"Yang I.V.; Wade C.M.; Kang H.M.; Identification of novel genes that mediate innate immunity using inbred mice. Genetics 2009,183(4),1535-1544","journal-title":"Genetics"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","volume":"189","author":"Haneklaus M.","year":"2012","unstructured":"Haneklaus M.; Gerlic M.; Kurowska-Stolarska M.; Cutting Edge: MiR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1\u03b2 Production. J Immunol 2012,189(8),3795-3799","journal-title":"J Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-9378-9-12","volume":"9","author":"Ambrosio M.R.","year":"2014","unstructured":"Ambrosio M.R.; Navari M.; Di Lisio L.; The epstein barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect Agent Cancer 2014,9(1),12","journal-title":"Infect Agent Cancer"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e00530","DOI":"10.1128\/JVI.00530-17","volume":"91","author":"Skinner C.M.","year":"2017","unstructured":"Skinner C.M.; Ivanov N.S.; Barr S.A.; Chen Y.; Skalsky R.L.; An epstein-barr virus MicroRNA blocks interleukin-1 (IL-1) signaling by targeting IL-1 receptor 1. J Virol 2017,91(21),e00530-e17","journal-title":"J Virol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.4049\/jimmunol.1501605","volume":"198","author":"Hooykaas M.J.G.","year":"2017","unstructured":"Hooykaas M.J.G.; van Gent M.; Soppe J.A.; EBV MicroRNA BART16 suppresses type I IFN signaling. J Immunol 2017,198(10),4062-4073","journal-title":"J Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1182\/blood.2019000889","volume":"134","author":"Cristino A.S.","year":"2019","unstructured":"Cristino A.S.; Nourse J.; West R.A.; EBV microRNA-BHRF1-2-5p targets the 3\u2032UTR of immune checkpoint ligands PD-L1 and PD-L2. Blood 2019,134(25),2261-2270","journal-title":"Blood"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1159\/000479749","volume":"9","author":"Lu Y.","year":"2017","unstructured":"Lu Y.; Qin Z.; Wang J.; Epstein-barr virus miR-BART6-3p inhibits the RIG-I pathway. J Innate Immun 2017,9(6),574-586","journal-title":"J Innate Immun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/cells9020499","volume":"9","author":"Ghasemi F.","year":"2020","unstructured":"Ghasemi F.; Gameiro S.F.; Tessier T.M.; Maciver A.H.; Mymryk J.S.; High levels of class I major histocompatibility complex mRNA are present in epstein\u2013barr virus-associated gastric adenocarcinomas. Cells 2020,9(2),499","journal-title":"Cells"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ajpath.2013.12.024","volume":"184","author":"Huang W.T.","year":"2014","unstructured":"Huang W.T.; Lin C.W.; EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-\u03b3-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma. Am J Pathol 2014,184(4),1185-1197","journal-title":"Am J Pathol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","volume":"8","author":"Skalsky R.L.","year":"2012","unstructured":"Skalsky R.L.; Corcoran D.L.; Gottwein E.; The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 2012,8(1),e1002484","journal-title":"PLoS Pathog"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0952-7915(91)90068-C","volume":"3","author":"Harding C.V.","year":"1991","unstructured":"Harding C.V.; Pathways of antigen processing. Curr Opin Immunol 1991,3(1),3-9","journal-title":"Curr Opin Immunol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.20160248","volume":"213","author":"Tagawa T.","year":"2016","unstructured":"Tagawa T.; Albanese M.; Bouvet M.; Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med 2016,213(10),2065-2080","journal-title":"J Exp Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/2211-5463.12027","volume":"6","author":"Alles J.","year":"2016","unstructured":"Alles J.; Menegatti J.; Motsch N.; miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing. FEBS Open Bio 2016,6(4),251-263","journal-title":"FEBS Open Bio"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1128\/JVI.00613-16","volume":"90","author":"Verhoeven R.J.A.","year":"2016","unstructured":"Verhoeven R.J.A.; Tong S.; Zhang G.; NF-\u03baB signaling regulates expression of epstein-barr virus bart micrornas and long noncoding rnas in nasopharyngeal carcinoma. J Virol 2016,90(14),6475-6488","journal-title":"J Virol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","volume":"113","author":"Albanese M.","year":"2016","unstructured":"Albanese M.; Tagawa T.; Bouvet M.; Epstein\u2013Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci 2016,113(42),E6467-E6475","journal-title":"Proc Natl Acad Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-07-5126","volume":"68","author":"Xia T.","year":"2008","unstructured":"Xia T.; O\u2019Hara A.; Araujo I.; EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 2008,68(5),1436-1442","journal-title":"Cancer Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1128\/JVI.00721-14","volume":"88","author":"Jung Y.J.","year":"2014","unstructured":"Jung Y.J.; Choi H.; Kim H.; Lee S.K.; MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1. J Virol 2014,88(16),9027-9037","journal-title":"J Virol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e1002193","DOI":"10.1371\/journal.ppat.1002193","volume":"7","author":"Qiu J.","year":"2011","unstructured":"Qiu J.; Cosmopoulos K.; Pegtel M.; A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 2011,7(8),e1002193","journal-title":"PLoS Pathog"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00705-016-3109-z","volume":"162","author":"Choi H.","year":"2017","unstructured":"Choi H.; Lee S.K.; TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU. Arch Virol 2017,162(2),369-377","journal-title":"Arch Virol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1128\/JVI.03159-12","volume":"87","author":"Choi H.","year":"2013","unstructured":"Choi H.; Lee H.; Kim S.R.; Gho Y.S.; Lee S.K.; Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol 2013,87(14),8135-8144","journal-title":"J Virol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12250-017-3996-5","volume":"32","author":"Zuo L.","year":"2017","unstructured":"Zuo L.; Yue W.; Du S.; An update: Epstein-Barr virus and immune evasion via microRNA regulation. Virol Sin 2017,32(3),175-187","journal-title":"Virol Sin"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1182\/blood-2017-07-794529","volume":"131","author":"Higuchi H.","year":"2018","unstructured":"Higuchi H.; Yamakawa N.; Imadome K.I.; Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma. Blood 2018,131(23),2552-2567","journal-title":"Blood"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"36783","DOI":"10.18632\/oncotarget.9170","volume":"7","author":"Song Y.","year":"2016","unstructured":"Song Y.; Li X.; Zeng Z.; Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Oncotarget 2016,7(24),36783-36799","journal-title":"Oncotarget"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/leu.2015.285","volume":"30","author":"Ma J.","year":"2016","unstructured":"Ma J.; Nie K.; Redmond D.; EBV-miR-BHRF1-2 targets PRDM1\/Blimp1: Potential role in EBV lymphomagenesis. Leukemia 2016,30(3),594-604","journal-title":"Leukemia"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e2353","DOI":"10.1038\/cddis.2016.253","volume":"7","author":"He B.","year":"2016","unstructured":"He B.; Li W.; Wu Y.; Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis 2016,7(9),e2353","journal-title":"Cell Death Dis"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12985-015-0441-y","volume":"12","author":"Gao L.","year":"2015","unstructured":"Gao L.; Ai J.; Xie Z.; Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children. Virol J 2015,12(1),208","journal-title":"Virol J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1620\/tjem.237.117","volume":"237","author":"Zhou C.","year":"2015","unstructured":"Zhou C.; Xie Z.; Gao L.; Profiling of EBV-encoded microRNAs in EBV-associated hemophagocytic lymphohistiocytosis. Tohoku J Exp Med 2015,237(2),117-126","journal-title":"Tohoku J Exp Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e0212027","DOI":"10.1371\/journal.pone.0212027","volume":"14","author":"Hartung A.","year":"2019","unstructured":"Hartung A.; Makarewicz O.; Egerer R.; EBV miRNA expression profiles in different infection stages: A prospective cohort study. PLoS One 2019,14(2),e0212027","journal-title":"PLoS One"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s40620-017-0462-2","volume":"31","author":"Hassan J.","year":"2018","unstructured":"Hassan J.; Dean J.; De Gascun C.F.; Plasma EBV microRNAs in paediatric renal transplant recipients. J Nephrol 2018,31(3),445-451","journal-title":"J Nephrol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0042-6822(87)90055-9","volume":"160","author":"Pearson G.R.","year":"1987","unstructured":"Pearson G.R.; Luka J.; Petti L.; Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 1987,160(1),151-161","journal-title":"Virology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/infdis\/jit222","volume":"208","author":"Kawano Y.","year":"2013","unstructured":"Kawano Y.; Iwata S.; Kawada J.; Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. J Infect Dis 2013,208(5),771-779","journal-title":"J Infect Dis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e1001063","DOI":"10.1371\/journal.ppat.1001063","volume":"6","author":"Seto E.","year":"2010","unstructured":"Seto E.; Moosmann A.; Gr\u00f6mminger S.; Walz N.; Grundhoff A.; Hammerschmidt W.; Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 2010,6(8),e1001063","journal-title":"PLoS Pathog"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13052-020-00949-7","volume":"47","author":"Shi J.","year":"2021","unstructured":"Shi J.; Chu C.; Yu M.; Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus. Ital J Pediatr 2021,47(1),3","journal-title":"Ital J Pediatr"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jcrc.2017.02.018","volume":"39","author":"Han X.","year":"2017","unstructured":"Han X.; Ye Q.; Zhang W.; Tang Y.; Xu X.; Zhang T.; Cytokine profiles as novel diagnostic markers of Epstein-Barr virus\u2013associated hemophagocytic lymphohistiocytosis in children. J Crit Care 2017,39,72-77","journal-title":"J Crit Care"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5217039","volume":"2020","author":"Zhang Q.","year":"2020","unstructured":"Zhang Q.; Luo D.; Xie Z.; He H.; Duan Z.; The oncogenic role of miR-BART19-3p in epstein-barr virus-associated diseases. BioMed Res Int 2020,2020,1-11","journal-title":"BioMed Res Int"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","volume":"39","author":"Imig J.","year":"2011","unstructured":"Imig J.; Motsch N.; Zhu J.Y.; microRNA profiling in Epstein\u2013Barr virus-associated B-cell lymphoma. Nucleic Acids Res 2011,39(5),1880-1893","journal-title":"Nucleic Acids Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/hon.2360","volume":"35","author":"Komabayashi Y.","year":"2017","unstructured":"Komabayashi Y.; Kishibe K.; Nagato T.; Ueda S.; Takahara M.; Harabuchi Y.; Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer\/T-cell lymphoma. Hematol Oncol 2017,35(4),655-663","journal-title":"Hematol Oncol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e27271","DOI":"10.1371\/journal.pone.0027271","volume":"6","author":"Ramakrishnan R.","year":"2011","unstructured":"Ramakrishnan R.; Donahue H.; Garcia D.; Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One 2011,6(11),e27271","journal-title":"PLoS One"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"Levine A.G.","year":"2017","unstructured":"Levine A.G.; Mendoza A.; Hemmers S.; Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 2017,546(7658),421-425","journal-title":"Nature"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.ajpath.2013.01.025","volume":"182","author":"Lin T.C.","year":"2013","unstructured":"Lin T.C.; Liu T.Y.; Hsu S.M.; Lin C.W.; Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK\/T-cell lymphoma. Am J Pathol 2013,182(5),1865-1875","journal-title":"Am J Pathol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2141.2008.07186.x","volume":"142","author":"Jun S.M.","year":"2008","unstructured":"Jun S.M.; Hong Y.S.; Seo J.S.; Ko Y.H.; Yang C.W.; Lee S.K.; Viral microRNA profile in Epstein-Barr virus-associated peripheral T cell lymphoma. Br J Haematol 2008,142(2),320-323","journal-title":"Br J Haematol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pathol.2019.09.006","volume":"52","author":"Marques-Piubelli M.L.","year":"2020","unstructured":"Marques-Piubelli M.L.; Salas Y.I.; Pachas C.; Becker-Hecker R.; Vega F.; Miranda R.N.; Epstein\u2013Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: A review. Pathology 2020,52(1),40-52","journal-title":"Pathology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1111\/ajt.12858","volume":"14","author":"Fink S.E.K.","year":"2014","unstructured":"Fink S.E.K.; Gandhi M.K.; Nourse J.P.; A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors. Am J Transplant 2014,14(11),2577-2587","journal-title":"Am J Transplant"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00508-016-1083-9","volume":"128","author":"Unger M.","year":"2016","unstructured":"Unger M.; Karanikas G.; Kerschbaumer A.; Winkler S.; Aletaha D.; Fever of unknown origin (FUO) revised. Wien Klin Wochenschr 2016,128(21-22),796-801","journal-title":"Wien Klin Wochenschr"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/310207a0","volume":"310","author":"Baer R.","year":"1984","unstructured":"Baer R.; Bankier A.T.; Biggin M.D.; DNA sequence and expression of the B95-8 Epstein\u2014Barr virus genome. Nature 1984,310(5974),207-211","journal-title":"Nature"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmicb.2017.00229","volume":"8","author":"Mundo L.","year":"2017","unstructured":"Mundo L.; Ambrosio M.R.; Picciolini M.; Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded MicroRNAs expression in EBER-negative burkitt lymphoma cases. Front Microbiol 2017,8,229","journal-title":"Front Microbiol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/ijms19041168","volume":"19","author":"Navari M.","year":"2018","unstructured":"Navari M.; Etebari M.; Ibrahimi M.; Leoncini L.; Piccaluga P.; Pathobiologic roles of epstein\u2013barr virus-encoded MicroRNAs in human lymphomas. Int J Mol Sci 2018,19(4),1168","journal-title":"Int J Mol Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pbc.22310","volume":"54","author":"Ohga S.","year":"2010","unstructured":"Ohga S.; Kudo K.; Ishii E.; Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 2010,54(2),299-306","journal-title":"Pediatr Blood Cancer"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"Cohen J.I.","year":"2011","unstructured":"Cohen J.I.; Jaffe E.S.; Dale J.K.; Characterization and treatment of chronic active Epstein-Barr virus disease: A 28-year experience in the United States. Blood 2011,117(22),5835-5849","journal-title":"Blood"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ped.12314","volume":"56","author":"Fujiwara S.","year":"2014","unstructured":"Fujiwara S.; Kimura H.; Imadome K.; Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int 2014,56(2),159-166","journal-title":"Pediatr Int"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3389\/fmicb.2017.02666","volume":"8","author":"Kaul V.","year":"2018","unstructured":"Kaul V.; Weinberg K.I.; Boyd S.D.; Dynamics of viral and host immune cell MicroRNA expression during acute infectious mononucleosis. Front Microbiol 2018,8,2666","journal-title":"Front Microbiol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.addr.2012.07.006","volume":"65","author":"Koppers-Lalic D.","year":"2013","unstructured":"Koppers-Lalic D.; Hogenboom M.M.; Middeldorp J.M.; Pegtel D.M.; Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine. Adv Drug Deliv Rev 2013,65(3),348-356","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2222\/jsv.64.43","volume":"64","author":"Kotani A.","year":"2014","unstructured":"Kotani A.; The role of tumor-derived secretary small RNAs in EBV related lymphoma. Uirusu 2014,64(1),43-48","journal-title":"Uirusu"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"20370","DOI":"10.1073\/pnas.1014194107","volume":"107","author":"Meckes D.G.","year":"2010","unstructured":"Meckes D.G.; Shair K.H.Y.; Marquitz A.R.; Kung C.P.; Edwards R.H.; Raab-Traub N.; Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci 2010,107(47),20370-20375","journal-title":"Proc Natl Acad Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/978-981-10-7230-7_22","volume":"1045","author":"Cohen J.I.","year":"2018","unstructured":"Cohen J.I.; Vaccine development for epstein-barr virus. Adv Exp Med Biol 2018,1045,477-493","journal-title":"Adv Exp Med Biol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3389\/fimmu.2019.02323","volume":"10","author":"Atherton L.J.","year":"2019","unstructured":"Atherton L.J.; Jorquera P.A.; Bakre A.A.; Tripp R.A.; Determining immune and miRNA biomarkers related to Respiratory Syncytial Virus (RSV) vaccine types. Front Immunol 2019,10,2323","journal-title":"Front Immunol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"Turchinovich A.","year":"2011","unstructured":"Turchinovich A.; Weiz L.; Langheinz A.; Burwinkel B.; Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011,39(16),7223-7233","journal-title":"Nucleic Acids Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"Wang J.","year":"2016","unstructured":"Wang J.; Chen J.; Sen S.; MicroRNA as biomarkers and diagnostics. J Cell Physiol 2016,231(1),25-30","journal-title":"J Cell Physiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e12745","DOI":"10.1371\/journal.pone.0012745","volume":"5","author":"Chen S.J.","year":"2010","unstructured":"Chen S.J.; Chen G.H.; Chen Y.H.; Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 2010,5(9),e12745","journal-title":"PLoS One"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2116\/analsci.30.59","volume":"30","author":"Kobori T.","year":"2014","unstructured":"Kobori T.; Takahashi H.; Expanding possibilities of rolling circle amplification as a biosensing platform. Anal Sci 2014,30(1),59-64","journal-title":"Anal Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1021\/ac3004055","volume":"84","author":"Alhasan A.H.","year":"2012","unstructured":"Alhasan A.H.; Kim D.Y.; Daniel W.L.; Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid-gold nanoparticle conjugates. Anal Chem 2012,84(9),4153-4160","journal-title":"Anal Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/DDDT.S288859","volume":"15","author":"Zhang S.","year":"2021","unstructured":"Zhang S.; Cheng Z.; Wang Y.; Han T.; The risks of miRNA therapeutics: In a drug target perspective. Drug Des Devel Ther 2021,15,721-733","journal-title":"Drug Des Devel Ther"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1038\/cti.2015.1","volume":"4","author":"Balfour H.H.","year":"2015","unstructured":"Balfour H.H.; Dunmire S.K.; Hogquist K.A.; Infectious mononucleosis. Clin Transl Immunology 2015,4(2),e33","journal-title":"Clin Transl Immunology"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"Young L.S.","year":"2016","unstructured":"Young L.S.; Yap L.F.; Murray P.G.; Epstein\u2013Barr virus: More than 50 years old and still providing surprises. Nat Rev Cancer 2016,16(12),789-802","journal-title":"Nat Rev Cancer"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","volume":"102","author":"Dunmire S.K.","year":"2018","unstructured":"Dunmire S.K.; Verghese P.S.; Balfour H.H.; Primary Epstein-Barr virus infection. J Clin Virol 2018,102,84-92","journal-title":"J Clin Virol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.coviro.2015.09.007","volume":"14","author":"Kempkes B.","year":"2015","unstructured":"Kempkes B.; Robertson E.S.; Epstein-Barr virus latency: Current and future perspectives. Curr Opin Virol 2015,14,138-144","journal-title":"Curr Opin Virol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-22822-8_6","volume":"390","author":"Hammerschmidt W.","year":"2015","unstructured":"Hammerschmidt W.; The epigenetic life cycle of epstein\u2013barr virus. Curr Top Microbiol Immunol 2015,390(Pt 1),103-117","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666221118122005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211046\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666221118122005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T12:21:40Z","timestamp":1703247700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211046\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524023666221118122005","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}